Exparel (Bupivacaine Liposome)
- Medicine Name: Exparel
- API: Bupivacaine Liposome
- Dosage Form & Strength: Injectable suspension: 266 mg/20 mL (13.3 mg/mL) & 133 mg/10 mL (13.3 mg/mL) single-dose vial
- Manufactured By: Pacira Pharmaceuticals, Inc.
Exparel (bupivacaine liposome injectable suspension) is used:
In patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia.
In adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.
Recommended Dosage:
Local Analgesia via Infiltration Dosing in Adults: The recommended dose for local infiltration in adults is up to a maximum dose of 266 mg (20 mL), and is based on the size of the surgical site, volume required to cover the area, and individual patient factors that may impact the safety of an amide local anesthetic.
Local Analgesia via Infiltration Dosing in Pediatric Patients: The recommended dose for single-dose infiltration in pediatric patients, aged 6 to less than 17 years, is 4 mg/kg (up to a maximum of 266 mg), and is based upon two studies of pediatric patients undergoing either spine surgery or cardiac surgery.
Regional Analgesia via Interscalene Brachial Plexus Nerve Block Dosing in Adults: The recommended dose for interscalene brachial plexus nerve block in adults is 133 mg (10 mL), and is based upon one study of patients undergoing either total shoulder arthroplasty or rotator cuff repair.
- Careful and persistent monitoring of cardiovascular and respiratory (adequacy of ventilation) vital signs and the patient’s state of consciousness need to be performed after bupivacaine injection and other amide-containing products.
- Toxic blood concentrations depress cardiac conductivity and excitability, which may lead to ventricular arrhythmias, atrioventricular block, and cardiac arrest, occasionally resulting in fatalities. In addition, myocardial contractility is depressed, and peripheral vasodilation occurs, leading to reduced cardiac output and arterial blood pressure.
- Cases of methemoglobinemia may occur in association with local anesthetic use. In case local anesthetics must be used in these patients, precise monitoring for signs and symptoms of methemoglobinemia is recommended.
- Caution should be considered to avoid accidental intravascular Exparel injection. Convulsions and cardiac arrest may occur following accidental intravascular injection of bupivacaine and other amide-containing products.
What documents are required to import EXPAREL to India?
EXPAREL (bupivacaine liposome injectable suspension) can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
EXPAREL (bupivacaine liposome) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Exparel in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of EXPAREL (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Exparel injection price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Exparel®?
Bupivacaine liposome is a Generic Name for the trade name drug Exparel®.
What is the Manufacturer’s Name of Exparel®?
Exparel® is manufactured by Pacira Pharmaceuticals, Inc.
Is Exparel® approved by the FDA?
Yes, Exparel® is approved by the FDA. Date of first approval: October 28, 2011.
What is the dosage and form of Exparel® supplied?
Exparel® is supplied as an injectable suspension: 266 mg/20 mL (13.3 mg/mL) and 133 mg/10 mL (13.3 mg/mL) single-dose vial.
What are the most common side effects of Exparel®?
The most common side effects of Exparel® following administration via infiltration in adults include constipation, nausea, and vomiting; and in pediatric patients aged 6 to less than 17 years include nausea, hypotension, anemia, vomiting, constipation, muscle twitching, blurred vision, pruritus, and tachycardia.
The most common side effects following administration via nerve block in adults include constipation, nausea, pyrexia, and headache.
How much does Exparel® cost in India?
The cost of Exparel in India can vary. To procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Exparel®?
Store the vials refrigerated between 2-8°C (36-46°F). It may be held at a controlled room temperature of 20-25°C (68-77°F) for up to 30 days in sealed, unopened vials. Avoid re-refrigerating vials.
Is it safe to buy Exparel® online in India?
Yes, one can buy Exparel online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Exparel® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.